Peter Hjelmström

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Drug development and industrial pharmacy

Addiction (Abingdon, England)

Camurus

Karolinska Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Camurus

Sweden

Medical Director

Alexion Pharmaceuticals

Sweden

Medical Affairs Manager

Orexo AB

Sweden

Chief Medical Officer

Swedish Orphan Biovitrum AB

Sweden

Head of Clinical Sciences

Biovitrum AB

Sweden

Medical Program Director

Serono International

Switzerland

Senior Scientific Advisor :: Research Alliance Management

Yale University School of Medicine

United States

Postdoctoral fellow :: Immunobiology

Education History

Karolinska Institute

Sweden

PHD :: Dept of Medicine

Stockholm University

Sweden

BSC

Publications

Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson, Kerstin Strandgården, Peter Hjelmström, Fredrik Tiberg
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson, Kerstin Strandgården, Peter Hjelmström, Fredrik Tiberg
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson, Kerstin Strandgården, Peter Hjelmström, Fredrik Tiberg
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson, Kerstin Strandgården, Peter Hjelmström, Fredrik Tiberg
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson, Kerstin Strandgården, Peter Hjelmström, Fredrik Tiberg
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Sharon L Walsh, Sandra D Comer, Jurij Aguiar Zdovc, Céline Sarr, Marcus Björnsson, Kerstin Strandgården, Peter Hjelmström, Fredrik Tiberg
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Anna Fugelstad, Sven G Bremberg, Peter Hjelmström, Ingemar Thiblin
Methadone-related deaths among youth and young adults in Sweden 2006-15. Addiction (Abingdon, England) 116 (2) (2020)
Peter Hjelmström, Elin Banke Nordbeck, Fredrik Tiberg
Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data. Drug development and industrial pharmacy 46 (1) (2020)

Peter Hjelmström.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Hjelmström